In brief: C3, SSH, Axon
Wednesday, 30 November, 2005
Clinical Cell Culture's (ASX:CCE) co-founder Prof Fiona Wood will step down from the company's board on December 31. She will remain as a consultant, an R&D partner through her research vehicle the McComb Foundation, and a substantial shareholder.
Shareholders at SSH Medical's (ASX:SSH) AGM yesterday approved a resolution to change the company's name to BioLayer Corporation, the unlisted Brisbane-based materials sciences company it acquired earlier this month.
Axon Instruments founder and former CEO Dr Alan Finkel has been appointed to the ATSE Clunies Ross board of governors. Finkel is the first winner of an ATSE Clunies Ross award to join the board.
Scientists uncover how cancer cells hide from immune system
By targeting the RNA helicase known as DDX6, scientists could enable the immune system to...
Vanillin flavouring in vapes may disrupt embryo development
Vanillin — a common flavouring chemical in e-cigarettes — may disrupt the normal...
Heart valve tissues created from stem cells
The breakthrough should help advance our understanding into how human heart valves develop,...
